荷兰不可切除局部复发直肠癌非手术放疗全国调查
23名来自18家荷兰机构的放射肿瘤科医生完成调查,结果显示放疗适应证存在共识,但剂量分割方案和靶区勾画差异显著,疗效评估和随访无共识。
要点
- 不可切除局部复发直肠癌非手术放疗的适应证存在共识。
- 剂量分割方案和靶区勾画存在显著差异。
- 疗效评估和随访方案无共识,需前瞻性研究。
核心结论
- 荷兰全国调查显示不可切除局部复发直肠癌非手术放疗的剂量分割、靶区勾画和随访存在显著异质性且缺乏共识。
主要发现
- 23名来自18家荷兰机构的放射肿瘤科医生完成调查。
- 放疗适应证存在共识,但剂量分割方案和靶区勾画差异显著。
- 疗效评估和随访方案无共识。
- 临床挑战包括患者异质性、缺乏循证指南、放射毒性知识有限、预后评估困难和处理难治性症状。
临床怎么用
- 临床需关注不可切除局部复发直肠癌非手术放疗的剂量分割和靶区勾画差异,并推动前瞻性研究以优化方案。
局限性
- 调查仅覆盖荷兰18家机构23名医生,样本量有限,结果可能不能代表更广泛实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Over half of patients with locally recurrent rectal cancer (LRRC) are ineligible for curative-intent multimodality treatment, typically including neoadjuvant treatment followed by surgery, due to unresectable disease, distant metastases, and/or frailty. Non-operative management for unresectable LRRC may include (chemo)(re-)irradiation, but evidence remains scarce. This study explores the current clinical practice of radiotherapy for LRRC in the Netherlands within this setting. MATERIALS AND METHODS: A web-based survey was designed and distributed to members of the Dutch Society of Radiation Oncology between December 2024 and February 2025. The survey comprised 28 items, addressing clinical indications, target delineation, treatment planning, dose and fractionation, radiotherapy techniques and knowledge gaps in current clinical practice. RESULTS: 23 radiation oncologists from 18 out of 21 Dutch institutes completed the survey. While agreement existed regarding indications for radiotherapy in the non-operative management for LRRC, marked variability was observed in dose and fractionation schedules and target volume delineation. There seemed to be no consensus on response evaluation or follow-up schedules. Reported clinical challenges included patient heterogeneity, absence of evidence-based guidelines, limited knowledge on radiation-induced toxicity, difficulties estimating prognosis and management of therapy-resistant symptoms. CONCLUSIONS: This national survey highlights the clinical heterogeneity and lack of consensus regarding radiotherapy for unresectable LRRC. Variations in dose and fractionation schedules, target volume delineation and follow-up underscore the need for prospective studies. Future research initiatives should prioritize optimal dose and fractionation schedules and the role of dose escalation, while integrating quality assurance programs and patient-reported outcomes to guide development of evidence-based recommendations for this complex patient group.
引用
- Vande Kerckhove FEC, Verrijssen AE, Tijssen RHN, et al. Current clinical practice of radiotherapy for the non-operative treatment of patients with unresectable locally recurrent rectal cancer: results of a national survey of the dutch society for radiotherapy and oncology. Radiat Oncol. 2026. PMID: 42426862. doi:10.1186/s13014-026-02890-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。